An observational study in Chronic Renal Failure and Renal Insufficiency, Chronic, sponsored by Clinique Néphrologique Saint-Exupéry. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-11-16.
Sponsored by Clinique Néphrologique Saint-Exupéry · Observational
Chronic hemodialysis is often associated with a reduction in the quality of life of patients and a reduction in physical activity, due to the repeated frequency of sessions.
Various studies conducted in hemodialysis patients have shown the beneficial effects of physical exercise during hemodialysis sessions on reducing cardiovascular risk, the number of hospitalizations and improving quality of life. It also contributes to improved patient adherence to care.
Finally, it has been shown that exercise during the hemodialysis session is safe for the patient and does not disrupt dialysis parameters.
Nevertheless, there are no data on the medico-economic impact of such a program.
Based on the investigators' experience, the investigators have developed a specific protocol linking the different types of physical activity that have provided evidence of their efficiency and used in standard practice in the investigators' institutions. From tests and questionnaires assessing the physical abilities of patients have already validated for this population in this pathology.
The objective of this project is to show the medico-economic interest of an adapted physical activity program for hemodialysis patients.
1,995 studies on the registry are indexed under Renal Insufficiency; 173 are open to participants now.
This study's enrollment of 52 is below the median of 149 across 394 observational studies indexed under Renal Insufficiency.
Browse Renal Insufficiency studies →This is the only study on the registry with Clinique Néphrologique Saint-Exupéry as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Haemodialysis patient, of full age, for more than 12 months and in front of benefiting/benefiting from a physical activity program
Exclusion Criteria:
Variation in direct and indirect medical costs
Evaluation of medical costs between the 12 months prior to the start of the adapted physical activity program and the 12 months following the start of the adapted physical activity program.
Time frame: through study completion, an average of 1 year
change in the quality of life score
Assessed by a The Short Form (36) (SF-36 scale) interpreted by an algorythm
Time frame: baseline, at 6 months and at one year
change in body mass index, weight and height will be combined to report BMI in kg/m^2
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in blood presure in mmHg
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in rate of haemoglobin in g/dL
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in percentage of hematocrit and saturation coefficient in %
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in rate of ferritin in ug/L
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in rate of urea, transferrin and blood sugar in g/L
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in rate of potassium in mEq/L
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in rate of bicarbonate in mmol/L
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in rate of calcium, phosphore and C-reactiv protein in mg/L
obtained in start of hemodialysis session
Time frame: every month, up to 12 months
change in physical activity evaluation score, from 0 (better) to 20 (worse)
obtained thanks to Borg scale
Time frame: baseline, at 6 months and at one year
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.